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Abstract Fibroblasts are heterogeneous mesenchymal cells
that play important roles in the production and maintenance
of extracellular matrix. Although their heterogeneity is
recognized, progenitor progeny relationships among fibro-
blasts and the factors that control fibroblast differentiation
are poorly defined. The current study was designed to
develop a reliable method that would permit in vitro
differentiation of fibroblast-like cells from human and
murine embryonic stem cells (ESCs). Undifferentiated
ESCs were differentiated into embryoid bodies (EBs) with
differentiation media. EBs were then cast into type I
collagen gels and cultured for 21 d with basal media. The
spindle-shaped cells that subsequently grew from the EBs
were released from the gels and subsequently cultured as
monolayers in basal media supplemented with serum.
Differentiated cells showed a characteristic spindle-shaped
morphology and had ultrastructural features consistent with
fibroblasts. Immunocytochemistry showed positive staining
for vimentin and alpha-smooth muscle actin but was
negative for stage-specific embryonic antigens and cytoker-
atins. Assays of fibroblast function, including proliferation,
chemotaxis, and contraction of collagen gels demonstrated
that the differentiated cells, derived from both human and
murine ESCs, responded to transforming growth factor-β1
and prostaglandin E2 as would be expected of fibroblasts,
functions not expected of endothelial or epithelial cells. The
current study demonstrates that cells with the morphologic
and functional features of fibroblasts can be reliably derived
from human and murine ESCs. This methodology provides
a means to investigate and define the mechanisms that
regulate fibroblast differentiation.
Keywords Embryonic stem cell differentiation.
Fibroblasts.Three-dimensional collagen gel cultures
Introduction
Fibroblasts represent a heterogeneous population of mes-
enchymal cells that play important roles in the production
and maintenance of extracellular matrix (Raghow 1994;
Ohnishi et al. 1998; Phan 2008). In addition, fibroblasts
have important regulatory roles modulating the function of
many other cell types (Knight 2001; Nanki et al. 2001;
Rennard 2001; Hay 2005). While fibroblast heterogeneity is
clearly recognized, progenitor progeny relationships among
fibroblasts and the factors that control fibroblast differen-
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DOI 10.1007/s11626-010-9367-2tiation are poorly defined. This is, to a significant degree,
complicated by a lack of surface markers to define
differentiated fibroblast phenotypes. Fibroblasts, therefore,
are, at the present time, best characterized by morphology,
ultrastructure, and function supported by molecular marker
expression (Powell et al. 1999a; Powell et al. 1999b;
Fireman et al. 2001; Eyden 2004; Eyden 2005).
The ultimate progenitor cell is the embryonic stem cell
( E S C ) ,w h i c hi ni nv i t r oc u l t u r es y s t e m s ,E C S sc a n
differentiate in to cells of many lineages. Interestingly, the
culture of ESCs is most commonly accomplished by co-
culture with fibroblast feeder layers, which provide undefined
but necessary cofactors. Because xenogenic fibroblasts
present a number of theoretical and technical problems,
several investigators have described methods to prepare
autogenic and syngenic fibroblasts from ESCs to use as
feeder layers for ESCs (Xu et al. 2004; Stojkovic et al. 2005;
Yoo et al. 2005;C h o oe ta l .2008;C h e ne ta l .2009).
However, these studies have not demonstrated that the
fibroblast-like cells function like fibroblasts, which would
be a necessary step toward an experimental system to
delineate the differentiation pathways leading to heteroge-
neous populations of fibroblasts. The current study, there-
fore, was designed to develop a reliable methodology that
would permit in vitro differentiation of fibroblasts from
human and murine ESCs. The development of this method-
ology provides a means for delineating the mechanisms that
control fibroblast differentiation and that lead to functionally
heterogeneous mature cell populations.
Materials and Methods
Materials. Native type I collagen (rat tail tendon collagen
[RTTC]) was extracted from rat-tail tendons by a
previously published method (Elsdale and Bard 1972).
Commercially available reagents were obtained as follows:
transforming growth factor (TGF)-β1w a sf r o mR & D
Systems (Minneapolis, MN); prostaglandin E2 (PGE2),
monoclonal anti-α-smooth muscle actin (SMA), anti-pan
cytokeratin monoclonal, anti-vimentin monoclonal anti-
bodies, anti-mouse IgG FITC (fluorescein isothiocyanate
stain-green immunofluorescence) conjugate, propidium
iodide and 2-mercaptoethanol were from Sigma (St. Louis,
MO); ESGRO® (leukemia inhibitory factor; LIF), anti-
stage specific embryonic antigen (SSEA)-1 and 4 mono-
clonal antibodies were from Chemicon International
(Temecula, CA); Dulbecco’s modified eagle’sm e d i u m
(DMEM), fetal calf serum (FCS), DMEM/F12 [1:1
mixture], KnockOut™ serum replacement, KnockOut™
DMEM, non-essential amino acids, L-glutamine, basic
fibroblast growth factor (bFGF), collagenase type IV, and
0.05% Trypsin-EDTAwere from Invitrogen (Carlsbad, CA).
Cell culture and differentiation. Human ESCs Culture. The
National Institutes of Health-approved human embryonic
stem cell line H9.2 (passages 45–65; WiCell Research
Institute, Madison, WI) was used in this study with the
approval of the Institutional Review Board and Embryonic
Stem Cell Research Oversight committee of the University
of Nebraska Medical Center. Undifferentiated human ESCs
were cultured on irradiated mouse embryonic fibroblasts
(MEF) in six-well plates with human ESC culture medium
containing 80% DMEM/F12, 20% KnockOut™ serum
replacement, 1% non-essential amino acids, 1 mmol/lL-
glutamine, 0.1 mmol/l 2-mercaptoethanol, and 4 ng/ml
bFGF. Colonies were mechanically dissected with finely
pulledglass micropipettes (1.0mm OD; Clark Electromedical
Instruments, Reading, UK) every 7 d and transferred to a
freshly prepared MEF layer.
Culture of embryoid bodies in type I collagen gels. To
prepare embryoid bodies (EBs), human ESCs from four- to
five-wells of a six-well plate were treated with 1 mg/ml
collagenase and cells were collected by centrifugation at
200×g for 2 min. The pellet was resuspended in differenti-
ation medium containing 90% DMEM/F12, 10% Knockout
serum replacement, 1% non-essential amino acids, and
1m m o l / l L-glutamine without 2-mercaptoethanol and bFGF
(Schuldiner et al. 2000). Cells were then placed into a Petri
dish (Sarstedt, Nümbrecht, Germany) and cultured for 4–5d .
Floating EBs from the Petri dish were collected into a 50 ml
polypropylene conical tube (Falcon; Becton-Dickinson
Labware, Franklin Lakes, NJ) and precipitated without
centrifugation.
Collagen gels were prepared as described previously
(Mio et al. 1996). Briefly, RTTC, distilled water and 4×
concentrated DMEM were combined so that the final
mixture resulted in 0.75 mg/ml collagen, with a physiologic
ionic strength of 1× DMEM at pH 7.4. EBs from a Petri
dish were then suspended in the neutralized collagen
solution. Aliquots (1.0 ml/well) of the mixture of EBs in
collagen were then cast into each well of a 12-well tissue
culture plate (Falcon) and allowed to polymerize. After
polymerization was completed, normally within 20 min at
room temperature, basal medium (1:1 mixture of differen-
tiation medium and DMEM/F12) was added on the top of
the gels in a 12-well plate (1.0 ml/well). The basal medium
was changed every 2–3 d and EBs were cultured for 21 d in
type I collagen gels.
Murine ESCs and EBs culture. The murine embryonic stem
cell line (CRL-11632) was obtained from the American
Type Culture Collection (Rockville, MD). KnockOut™
DMEM with 20% KnockOut serum replacement, 1% non-
essential amino acid, 1 mmol/lL-glutamine, 0.1 mmol/l
2-mercaptoethanol and 10
3 units/ml LIF was used for
DIFFERENTIATION OF EMBRYONIC STEM CELLS 115culture medium, and KnockOut™ DMEM with 2% FCS
for basal medium. Murine ESCs and EBs were cultured
using the same methods as human cells.
Differentiated fibroblast culture. The gels in a 12-well
culture plate were dissolved with 1 mg/ml collagenase at
37°C in a 5% CO2 atmosphere for 1 h. The resulting cells
were resuspended with DMEM containing 10% FCS (10%
FCS-DMEM) and centrifuged at 200×g for 5 min. The
cells, containing EBs, were cultured in a 100 mm tissue
culture dish (Falcon) with DMEM containing 10% FCS, 45
units/ml penicillin, 45 μg/ml streptomycin, and 1 μg/ml
amphotericin B. When near confluent, the cells were
trypsinized gently to prevent EBs from detaching and the
cells were passaged in 10% FCS-DMEM (Fig. 9). Cultures
were routinely inspected using phase contrast microscopy
and cells were assessed after 4–5 passages.
Collagen gel contraction assay. Collagen gels were
prepared as described previously (Mio et al. 1996).
Differentiated fibroblasts were trypsinized and mixed with
the neutralized collagen solution so that the final cell
density in the collagen solution was 3×10
5 cells/ml.
Aliquots (0.5 ml/well) of the mixture of cells in collagen
were cast into each well of 24-well tissue culture plates
(Falcon) and the mixture was allowed to polymerize. After
polymerization was completed, the gels were gently
released from the 24-well tissue culture plates and
transferred into 60-mm tissue culture dishes (three gels in
each dish) which contained 5 ml of freshly prepared serum-
free DMEM (SF-DMEM) with or without 10
−10 mol/l TGF-
β1o r1 0
−7 mol/l PGE2. The gels were then incubated at
37°C in a 5% CO2 atmosphere for 5 d. Gel contraction was
quantified using an Optomax V image analyzer (Optomax,
Burlington, MA) daily. Data were expressed as percentage
of the initial gel size.
Chemotaxis assay. Cell migration was assessed using the
Boyden blindwell chamber (Neuroprobe Inc., Gaithersburg,
MD) as previously described (Boyden 1962). Briefly, 26 μl
of SF-DMEM containing human fibronectin (20 μg/ml)
was placed into the bottom wells. Eight-micrometer pore
polycarbonate membranes (Neuroprobe Inc.), which were
precoated with 5 μg/ml gelatin in 0.1% acetic acid, were
employed. Cells were trypsinized and suspended with 10%
FCS-DMEM to stop the trypsin. Cells were then pelletted
and re-suspended in SF-DMEM at a density of 1×10
6/ml.
Fifty microliters of the cell suspension supplemented with
or without TGF-β1 (10
−10 mol/l) or PGE2 (10
−7 mol/l)
were then added into each top well. Cells were allowed to
migrate at 37°C in a 5% CO2 atmosphere for 12 h. Cells
that had not migrated were scraped off the upper surface of
the membrane, and the membranes were air-dried. Cells
were then stained with PROTOCOL (Fisher Scientific,
Day10, x40 Day0 EB, x40
Day21,x100 Day21, x40
(B) (A)
(D) (C)
Figure 1. Morphology of
human EBs differentiating in
type I collagen gel culture. EBs
were cast into type I collagen
gels and allowed to differentiate
for 21 d. (A) Day 0, (B) day 10,
(C) day 21 (original magnifica-
tion, ×40), (D) higher magnifi-
cation (×100) demonstrating
spindle-shaped cells surrounding
differentiated EBs (arrows).
116 TOGO ET AL.Swedesboro, NJ) and mounted on a glass microscope slide.
Chemotaxis was assessed by counting the number of cells
in five high-power fields.
Proliferation assay. Cells were plated into 12-well plates
(10
5 cells per each well) in 10% FCS-DMEM with or
without 10
−10 mol/l TGF-β1o r1 0
−7 mol/l PGE2. Cells
were fed with fresh 10% FCS-DMEM every 2 d. Cell
numbers from three separate wells were determined after
24, 72, and 120 h using a Coulter electronic cell counter
(Beckman Coulter Inc., Fullerton, CA).
Immunohistochemistry. Differentiated EBs in type I colla-
gen gels were fixed in 4% paraformaldehyde for 30 min.
Differentiated fibroblasts were cultured until sub-confluent
in eight chamber slides (Nunc Inc, Naperville, IL) in 10%
FCS-DMEM and fixed in 4% paraformaldehyde for 30 min
at passage 4. Cells were washed briefly with phosphate
buffered saline followed by permeabilization with 0.1%
Triton in sodium citrate buffer at 4°C for 5 min. After
blocking with horse serum, the cells were incubated with
monoclonal anti-α-SMA (1:200 dilution), anti-pan cytoker-
atin (1:200), anti-vimentin (1:200), anti-SSEA-1 (1:100), or
anti-SSEA-4 (1:100) antibodies at 4°C overnight. After
washing, cells were then incubated with FITC-conjugated
anti-mouse IgG antibody followed by nuclear staining with
propidium iodide. Stained cells were visualized and photo-
graphed using a Nikon Eclipse TE300 microscope (Nikon,
Tokyo, Japan) equipped with a DP71 digital camera
(Olympus, Tokyo, Japan).
SSEA-4 SSEA-1
Vimentin Cytokeratin
-SMA
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Figure2. Immunocytochemistry
of differentiating human EBs
in type I collagen gel culture.
EBs were cast into three-
dimensional collagen gels and
allowed to differentiate. On
day 21, cellular biomarkers were
evaluated by immunocytochem-
istry. (A) SSEA-4, (B) SSEA-1,
(C) vimentin, (D) cytokeratin,
(E) α-SMA (original magnifica-
tion, ×200).
DIFFERENTIATION OF EMBRYONIC STEM CELLS 117Electron microscopic examination. Cells were cultured on
Thermanox™ coverslips (Thermo Fisher Scientific,
Rochester, NY) and fixed in 2% glutaraldehyde, 2%
paraformaldehyde, and 0.5% acrolein. After washing with
0.1 mol/l Sorenson’s phosphate buffer, samples were post-
fixed in 1% osmium tetroxide. Samples were then washed
with buffer and dehydrated in a graded ethanol series. After
dehydration samples were embedded in Araldite. Thin
sections were stained with 2% uranyl acetate and Reynolds
lead citrate, and examined using a Philips 410LS transmis-
sion electron microscope (Philips Electronics, Eindhoven,
The Netherlands) operated at 60Kv. Images were acquired
with an Advanced Microscopy Techniques digital imaging
system (Danvers, MA).
Statistical analysis. Data were expressed as means±
standard error of the mean (SEM). Experiments with
multiple comparisons were evaluated using one-way
analysis of variance followed by Bonferroni’st e s t .F o r
all comparisons, significance was determined using separate
experiments performed on different occasions. Probability
values of <0.05 were considered significant.
Results
Differentiation of human ESCs into fibroblast-like cells in
three-dimensional type I collagen gel culture. Generally,
spindle-shaped cells appeared surrounding human EBs after
SSEA-4 SSEA-1
Vimentin
Cytokeratin
-SMA
(A) (B)
(C)
(E)
(D)
Figure3. Immunocytochemistry
of differentiated fibroblasts in
monolayer culture. Collagen gels
in which EBs had been cultured
for 21 d were dissolved with
collagenase and the cells were
passaged into monolayer culture.
At passage 4, cellular biomarkers
were assessed by immunocyto-
chemistry. (A) SSEA-4, (B)
SSEA-1, (C) vimentin, (D)
cytokeratin, (E) α-SMA (original
magnification, ×200).
118 TOGO ET AL.7–10 d of culture in three-dimensional type I collagen gels,
and were increasingly prominent with further culture to
day 21 (Fig. 1). The spindle-shaped cells were collected
following collagenase treatment and re-plated into tissue
culture plates in 10% FCS-DMEM. The EBs were also
released from the collagen gel, but remained floating and
were lost with serial feeding and passaging. The fibroblast-
like cells were used at passage 4–6 for subsequent
characterization.
To evaluate the differentiation of human EBs in three-
dimensional type I collagen gels, we first assessed several
markers of cell differentiation by immunocytochemistry.
EBs in collagen gels were SSEA-4 positive, a marker for
undifferentiated embryonic stem cells, but SSEA-1 negative
(Fig. 2A, B). Spindle-shaped cells surrounding the EBs
were positive for vimentin and negative for cytokeratin
(Fig. 2C, D). The leading edge of the spindle-shaped cells
showed positive staining for α-SMA (Fig. 2E). We also
stained fibroblast-like cells in monolayer culture. These
cells were negative for both SSEA-4 and SSEA-1 (Fig. 3A,
B). In contrast, fibroblast-like cells in monolayer culture
showed positive staining for vimentin in 96% of cells
(Fig. 3C) and for α-SMA in 92% of cells (Fig. 3D). They
were entirely negative for cytokeratin (Fig. 3E). We further
assessed the ultra-structural feature of the fibroblast-like cells
derived from human ESCs by transmission electron micros-
copy. Cells showed a characteristic spindle-shaped morphol-
ogy with prominent rough endoplasmic reticulum and stress
fibers, which were consistent with fibroblasts and myofibro-
blasts (Figs. 4A, B;D e l l ’Orbo et al. 1992).
Characteristics of differentiated fibroblast-like cells. To
assess the functional features of the fibroblast-like cells,
we evaluated cell proliferation, chemotaxis, and contraction
of three-dimensional type I collagen gels mediated by the
differentiated fibroblasts. In addition, we investigated the
ability of exogenous TGF-β1 or PGE2 to modulate each
function.
Differentiated fibroblasts slowly grew in 10% FCS-
DMEM with longer than 48 h of doubling time (Fig. 5).
Exogenous TGF-β1 significantly stimulated cell prolifera-
tion, whereas PGE2 significantly suppressed proliferation
(Fig. 5). Ability of cell migration was assessed by the
chemotaxis assay using fibronectin as a chemoattractant.
Consistent with our previous reports on lung fibroblast
chemotaxis (Kohyama et al. 2002), ESC-differentiated
fibroblasts migrated towards fibronectin. Furthermore,
exogenous PGE2 significantly inhibited, while TGF-β1
slightly but (not significant) augmented chemotaxis of these
cells towards fibronectin (Fig. 6). These differentiated
fibroblasts could also contract type I collagen gels when
they were cast into the gels and cultured in SF-DMEM,
which is considered as an in vitro model of tissue repair.
Collagen gel contraction was significantly augmented by
TGF-β1 but inhibited by PGE2 at all time points assessed
(Fig. 7).
Figure 4. Ultra-structure of
fibroblasts derived from human
ESCs. Cells were cultured on
Araldite coverslips for transmis-
sion electron microscopy. Cells
derived from human ESCs
showed a characteristic spindle-
shaped morphology with a
prominent rough endoplasmic
reticulum and stress fibers
(A: magnification, ×2,400; (B)
magnification ×14,000).
DIFFERENTIATION OF EMBRYONIC STEM CELLS 119Differentiation of murine ESCs into fibroblast-like cells.
Having demonstrated that culture of human ESCs in three-
dimensional type I collagen gels led to differentiation of
fibroblast-like cells, we next sought to determine if similar
results would be obtained with murine ESCs.
Spindle-shaped cells appeared after 10–14 d of culture of
murine EBs in three-dimensional collagen gels (Fig. 8A–D).
To evaluate the phenotype of these fibroblast-like cells, we
performed immunocytochemical staining for vimentin and
cytokeratin in monolayer culture. As expected, these cells
showed positive staining for vimentin, but were negative
for cytokeratin (Fig. 8E, F). It was also demonstrated that
exogenous TGF-β1 significantly augmented chemotactic
activity toward fibronectin and collagen gel contraction of
the fibroblast-like cells derived from murine ESCs, whereas
PGE2 significantly inhibited both chemotaxis and gel
contraction (Fig. 8G, H).
Discussion
Fibroblasts represent a heterogeneous population of cells
present in mesenchymal connective tissues (Fries et al.
1994; Powell et al. 1999a; Powell et al. 1999b; Phan 2008).
These cells are thought to be the major cells responsible for
the production and maintenance of extracellular matrix
(Raghow 1994; Ohnishi et al. 1998). In addition, fibroblasts
produce mediators that regulate epithelial and endothelial
cell proliferation and functions (Roberts and Sporn 1989;
Vignola et al. 1997). Fibroblasts, moreover, can also
regulate inflammatory cell recruitment and activation
(Glaros et al. 2009).
Cytokines can modulate fibroblast functions (Scotton
and Chambers 2007). TGF-β, for example, induces the
expression of α-SMA and increases fibroblast production
of extracellular matrix (Ronnov-Jessen and Petersen 1993;
Desmouliere and Gabbiani 1994). Cells with these features
are sometimes termed “myofibroblasts” as the increased
expression of α-SMA containing fibers resembles the fibers
present in smooth muscle cells (Hinz et al. 2007). In
addition to mediator-induced modulation of structure and
function, which may be transient, heterogeneous popula-
tions of fibroblasts with stable phenotypes have been
described in many tissues (Fries et al. 1994;C a s s i m a ne ta l .
2002). Alterations in populations of differentiated fibro-
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Figure 7. Contraction of three-dimensional collagen gels by fibro-
blasts derived from human ESCs. Fibroblasts were cast into three-
dimensional collagen gels. The gels were released into SF-DMEM
supplemented with or without either 10
−10 mol/l TGF-β1o r1 0
−7 mol/
l PGE2. Gel size was measured daily by an image analyzer. Vertical
axis gel size (percentage of initial area), horizontal axis time (d). Each
point represents mean±SEM of five separate experiments, each
performed in triplicate gels. Circles control, triangles PGE2, squares
TGF-β1; *p<0.01, compared with control group. SEMs are not
evident as they are within the plot symbols.
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Figure 6. Chemotaxis of fibroblasts derived from human ESCs.
Fibroblasts derived from differentiated EBs were trypsinized and
chemotaxis toward fibronectin (10 μg/ml) was assessed in the
presence or absence of either 10
−7 mol/l TGF-β1o r1 0
−7 mol/l PGE2.
Vertical axis percentage of fibronectin alone, horizontal axis conditions.
Each point represents the mean±SEM of three replicates in four
separate experiments; *p<0.05, compared to fibronectin alone
(control group).
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Figure 5. Effects of TGF-β1 and PGE2 on proliferation of fibroblasts
derived from human ESCs. Fibroblasts were cultured in monolayers in
10% FCS-DMEM with or without PGE2 (10
−7 mol/l) or TGF-β1
(10
−10 mol/l). Cells were detached with trypsin/EDTA and cell
numbers were determined using a Coulter electronic cell counter.
Vertical axis cell number (×10
5 cells/ml); horizontal axis, time (d).
Each point shows mean±SEM of three separate experiments, each of
which included triplicated wells. Circles control, triangles PGE2,
squares TGF-β1; *p<0.05, compared with control group. SEMs are
not evident as they are within the plot symbols.
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Figure 8. Differentiation of
murine ESCs into fibroblasts in
three-dimensional collagen gel
culture. (A) Murine ESCs
in monolayer culture with
feeder layer (original magnifi-
cation, ×400). (B) Murine EBs
were ready to cast into gels
(original magnification, ×200).
(C) Murine EBs in three-
dimensional collagen gels
(original magnification, ×200).
(D) Spindle-shaped cells
surrounding murine EBs as
indicated by the arrows (original
magnification, ×400). (E and F)
Immunocytochemistry of differ-
entiated murine fibroblasts in
monolayer culture stained for
vimentin (E) and cytokeratin (F)
(original magnification, ×200).
(G) Chemotaxis toward fibro-
nectin. Chemotaxis of murine
fibroblasts toward fibronectin
was assessed in the presence or
absence of either 5×10
−11 mol/
l TGF-β1o r1 0
−7 mol/l PGE2.
(H) Contraction of three-
dimensional collagen gels by
fibroblasts derived from murine
ESCs. Collagen gels containing
fibroblasts were floated in the
media with or without
10
−10 mol/TGF-β1o r1 0
−7 mol/
l PGE2. Circles control,
triangles PGE2, squares
TGF-β1; *p<0.05, compared
with control group.
DIFFERENTIATION OF EMBRYONIC STEM CELLS 121blasts, moreover, have been described in a number of disease
states (Kahari 1993; Fireman et al. 2001;H o l ze ta l .2004;
Sugiura et al. 2007;T o g oe ta l .2008;S a t oe ta l .in press).
The origin of differentiated fibroblasts is poorly under-
stood. Recent evidence suggests that circulating cells may
contribute as progenitors of tissue fibroblasts (Lama and
Phan 2006; Hinz et al. 2007; Hong et al. 2007; Phan 2008).
Little is known, however, about the mechanisms that
control differentiation of stem/progenitor cells into stable
populations of fibroblasts. The current study provides a
method for the evaluation of fibroblast differentiation from
embryonic stem cells as illustrated in Fig. 9.
Several other investigators have reported the derivation
of fibroblast-like cells from ESCs (Xu et al. 2004; Stojkovic
et al. 2005; Yoo et al. 2005; Choo et al. 2008; Chen et al.
2009). Both differentiation from embryoid bodies (Xu et al.
2004; Choo et al. 2008), as described in the current report,
and direct differentiation from ECS were used. All these
studies were designed to prepare non-xenogenic fibroblast-
like cells to use as feeder layers. The utility of the various
types of derived cells for this purpose was well established.
Much less attention has been given to demonstrating that
the derived cells function as fibroblasts. Yoo et al. (2005)
described their cells as being keratin negative and positive
for the enzyme prolyl hydroxylase, which plays a role in
collagen biosynthesis. Stojkovic et al. assessed a number of
histochemical markers, but the derived cells differed from
foreskin fibroblasts, which are a specific type of differen-
tiated cell.
Several lines of evidence support describing the
fibroblast-like cells prepared by the method described in
the current report as fibroblasts. First, these cells have the
characteristic spindle-shaped morphology of fibroblasts. In
addition, the ultrastructure of the cells is consistent with
that of fibroblasts/myofibroblasts. Finally, cells cultured in
the present study expressed the cytoskeletal protein vimen-
Culture in 100 mm culture dish
Gels are dissolved by collagenase
EBs are cast into collagen gels
EBs in Petri dish for 4-5 days
ESCs in 6-well plate
Figure 9. Schematic illustration
of the method for differentiation
of ESCs into fibroblasts in three-
dimensional type I collagen gel
culture. Undifferentiated ESCs
are cultured on MEF feeder
layer in six-well plate. ESCs are
detached with collagenase and
re-suspended with differentia-
tion medium. Cells are then
placed into a Petri dish and
cultured for 4–5 d to allow
formation of EBs. EBs are cast
into type I collagen gels in a
12-well plate (1.0 ml/well) and
cultured for 21 d three-
dimensionally in collagen gels
with basal medium. Gels are
dissolved by collagenase and the
cells are suspended in 10%
FCS-DMEM. Differentiated
fibroblasts are cultured in
100 mm culture dishes. EBs are
lost with serial feeding and
passaging.
122 TOGO ET AL.tin, which is characteristically present in fibroblasts, and
lacked the cytoskeletal protein cytokeratin, which is
characteristically present in epithelial cells.
A major distinction between fibroblasts on the one hand
and epithelial cells and endothelial cells on the other are
their responses to PGE2 and TGF-β (Liu et al. 2000;
Umino et al. 2000; Zhu et al. 2000). In general, TGF-β
inhibits epithelial cell proliferation and migration (Vignola
et al. 1997). In contrast, TGF-β augments proliferation and
migration of fibroblasts (Kurosaka et al. 1998; Togo et al.
2008). Similarly, PGE2 characteristically stimulates prolif-
eration and migration of epithelial cells while it inhibits
proliferation and migration of fibroblasts (Zhu et al. 2000;
Huang et al. 2007; Stenson 2007; Togo et al. 2008). Cells
cultured in the current study responded to PGE2 and TGF-β
in a manner characteristic of fibroblasts. In addition,
fibroblasts cultured in three-dimensional collagen gels
attached to collagen and exerted mechanical tension,
resulting in gel contraction. This property is thought to be
a model of tissue reorganization (Mio et al. 1996).
Characteristically, TGF-β augments and PGE2 inhibits this
process in fibroblasts (Campbell et al. 2004; Togo et al.
2008) as was observed in the cells prepared in the current
study. In contrast, the ability of endothelial and epithelial
cells to contract collagen gels differs markedly. Endothelial
cells are unaffected by TGFß or PGE (Liu et al. 2000)
and epithelial cells contract gels, but only when plated on
t h es u r f a c ea n dP G Eh a sn oe f f e c t( L i ue ta l .1998;U m i n o
et al. 2000).
In summary, the current study demonstrates that cells
with the morphologic and functional features of fibroblasts
can be reliably derived from human and murine ESCs. The
development of this methodology provides a means to define
the mechanisms that regulate fibroblast differentiation.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
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